ro 31-8220 has been researched along with Demyelinating Diseases in 1 studies
Ro 31-8220: a protein kinase C inhibitor
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baer, AS | 1 |
| Syed, YA | 1 |
| Kang, SU | 1 |
| Mitteregger, D | 1 |
| Vig, R | 1 |
| Ffrench-Constant, C | 1 |
| Franklin, RJ | 1 |
| Altmann, F | 1 |
| Lubec, G | 1 |
| Kotter, MR | 1 |
1 other study available for ro 31-8220 and Demyelinating Diseases
| Article | Year |
|---|---|
Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Animals, Newborn; Carbazoles; Cell Different | 2009 |